Previous proteomics studies have indicated a negative correlation between IGFBP2 levels and LVEF and proposed IGFBP2 as a candidate diagnostic biomarker for heart failure [23] and a strong prognostic factor for cardiovascular mortality. The gene discussed is IGFBP2; the disease is heart failure.